<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37016037</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>5528</StartPage><MedlinePgn>5528</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5528</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-32717-y</ELocationID><Abstract><AbstractText>Dysregulation of microRNAs (miRNA) in small extracellular vesicles (sEV) such as exosomes have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Although circulating cell-free miRNA have been extensively investigated in ALS, sEV-derived miRNAs have not been systemically explored yet. Here, we performed small RNA sequencing analysis of serum sEV and identified 5 differentially expressed miRNA in a discovery cohort of 12 patients and 11 age- and sex-matched healthy controls (fold change&#x2009;&gt;&#x2009;2, p&#x2009;&lt;&#x2009;0.05). Two of them (up- and down-regulation of miR-23c and miR192-5p, respectively) were confirmed in a separate validation cohort (18 patients and 15 healthy controls) by droplet digital PCR. Bioinformatic analysis revealed that these two miRNAs interact with distinct sets of target genes and involve biological processes relevant to the pathomechanism of ALS. Our results suggest that circulating sEV from ALS patients have distinct miRNA profiles which may be potentially useful as a biomarker of the disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Jin-Ah</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Canaria</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sung</LastName><ForeName>Jung-Joon</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Do-Jin</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seok-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Yoon-Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuroscience Research Institute, Medical Research Council, Seoul National University College of Medicine, Seoul National University Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea. nrhong@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Seoul Metropolitan Government Boramae Medical Center, 20 Boramaero-5-Gil, Dongjak-Gu, Seoul, 07061, Republic of Korea. nrhong@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074166">Circulating MicroRNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074166" MajorTopicYN="Y">Circulating MicroRNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37016037</ArticleId><ArticleId IdType="pmc">PMC10073149</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-32717-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-32717-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard SR, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021;92:510&#x2013;518. doi: 10.1136/jnnp-2020-325014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pmc">PMC8053339</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards D, Morren JA, Pioro EP. In: Amyotrophic Lateral Sclerosis. Araki T, editor. Exon Publications; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473440</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber NS, et al. Biomarkers in motor neuron disease: A state of the art review. Front. Neurol. 2019;10:291. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. (Lausanne) 2018;9:402. doi: 10.3389/fendo.2018.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G, Leigh PN, Newbury SF, Hafezparast M. An overview of microRNAs as biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C, Marzocchi C, Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018 doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez-Mo M, et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v4.27066</ArticleId><ArticleId IdType="pmc">PMC4433489</ArticleId><ArticleId IdType="pubmed">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, et al. Extracellular vesicles in neurodegenerative disease&#x2014;Pathogenesis to biomarkers. Nat. Rev. Neurol. 2016;12:346&#x2013;357. doi: 10.1038/nrneurol.2016.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.68</ArticleId><ArticleId IdType="pubmed">27174238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Keller S, Altevogt P, Costa J. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci. Lett. 2007;428:43&#x2013;46. doi: 10.1016/j.neulet.2007.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.024</ArticleId><ArticleId IdType="pubmed">17942226</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front. Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L, et al. Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J. Biol. Chem. 2013;288:7105&#x2013;7116. doi: 10.1074/jbc.M112.410944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.410944</ArticleId><ArticleId IdType="pmc">PMC3591620</ArticleId><ArticleId IdType="pubmed">23364798</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Cunha C, Barbosa M, Vaz AR, Brites D. Exosomes from NSC-34 cells transfected with hSOD1-G93A are enriched in miR-124 and drive alterations in microglia phenotype. Front. Neurosci. 2017;11:273. doi: 10.3389/fnins.2017.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00273</ArticleId><ArticleId IdType="pmc">PMC5434170</ArticleId><ArticleId IdType="pubmed">28567000</ArticleId></ArticleIdList></Reference><Reference><Citation>Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: A new source of biomarkers. Mutat. Res. 2011;717:85&#x2013;90. doi: 10.1016/j.mrfmmm.2011.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2011.03.004</ArticleId><ArticleId IdType="pmc">PMC3199035</ArticleId><ArticleId IdType="pubmed">21402084</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, et al. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis. Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2019;708:134176. doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: Towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol. 2020;10:200116. doi: 10.1098/rsob.200116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pregnolato F, et al. Exosome microRNAs in amyotrophic lateral sclerosis: a pilot study. Biomolecules. 2021 doi: 10.3390/biom11081220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081220</ArticleId><ArticleId IdType="pmc">PMC8394507</ArticleId><ArticleId IdType="pubmed">34439885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TW, et al. Extracellular vesicles in serum and central nervous system tissues contain microRNA signatures in sporadic amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2021;14:739016. doi: 10.3389/fnmol.2021.739016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.739016</ArticleId><ArticleId IdType="pmc">PMC8586523</ArticleId><ArticleId IdType="pubmed">34776863</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024&#x2013;1032. doi: 10.1038/ki.2012.256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.256</ArticleId><ArticleId IdType="pubmed">22785172</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan K, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci. Rep. 2020;10:1039. doi: 10.1038/s41598-020-57497-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57497-7</ArticleId><ArticleId IdType="pmc">PMC6978318</ArticleId><ArticleId IdType="pubmed">31974468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9&#x2013;18. doi: 10.1038/sj.cr.7290105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7290105</ArticleId><ArticleId IdType="pubmed">11942415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 2003;23:180&#x2013;192. doi: 10.1016/s1044-7431(03)00022-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1044-7431(03)00022-8</ArticleId><ArticleId IdType="pubmed">12812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerley S, et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 2004;26:354&#x2013;364. doi: 10.1016/j.mcn.2004.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2004.02.009</ArticleId><ArticleId IdType="pubmed">15207859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci. Rep. 2017;7:115. doi: 10.1038/s41598-017-00091-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00091-1</ArticleId><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs KL, et al. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. 2018;9:596. doi: 10.1038/s41419-018-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou P, et al. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44. Sci. Rep. 2019;9:19619. doi: 10.1038/s41598-019-56018-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56018-5</ArticleId><ArticleId IdType="pmc">PMC6928221</ArticleId><ArticleId IdType="pubmed">31873114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren FJ, Yao Y, Cai XY, Fang GY. Emerging role of MiR-192-5p in human diseases. Front. Pharmacol. 2021;12:614068. doi: 10.3389/fphar.2021.614068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.614068</ArticleId><ArticleId IdType="pmc">PMC7940509</ArticleId><ArticleId IdType="pubmed">33708127</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MD, et al. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J. Neurosci. 2003;23:2131&#x2013;2140. doi: 10.1523/JNEUROSCI.23-06-02131.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-06-02131.2003</ArticleId><ArticleId IdType="pmc">PMC6741997</ArticleId><ArticleId IdType="pubmed">12657672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003;162:823&#x2013;835. doi: 10.1016/s0002-9440(10)63879-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9440(10)63879-5</ArticleId><ArticleId IdType="pmc">PMC1868100</ArticleId><ArticleId IdType="pubmed">12598317</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick GN, et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999;402:615&#x2013;622. doi: 10.1038/45159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/45159</ArticleId><ArticleId IdType="pubmed">10604467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bk B, et al. Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model. Hum. Mol. Genet. 2019;28:3175&#x2013;3187. doi: 10.1093/hmg/ddz118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz118</ArticleId><ArticleId IdType="pmc">PMC6859439</ArticleId><ArticleId IdType="pubmed">31189016</ArticleId></ArticleIdList></Reference><Reference><Citation>Enderle D, et al. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS&#xa0;One. 2015;10:e0136133. doi: 10.1371/journal.pone.0136133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136133</ArticleId><ArticleId IdType="pmc">PMC4552735</ArticleId><ArticleId IdType="pubmed">26317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deun J, et al. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods. 2017;14:228&#x2013;232. doi: 10.1038/nmeth.4185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4185</ArticleId><ArticleId IdType="pubmed">28245209</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt Removes Adapter Sequences from High-Throughput Sequencing Reads. EMBnet.journal; 2011. pp. 10&#x2013;12.</Citation></Reference><Reference><Citation>Kozomara A, Griffiths-Jones S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68&#x2013;D73. doi: 10.1093/nar/gkt1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1181</ArticleId><ArticleId IdType="pmc">PMC3965103</ArticleId><ArticleId IdType="pubmed">24275495</ArticleId></ArticleIdList></Reference><Reference><Citation>The RC, et al. RNAcentral: A comprehensive database of non-coding RNA sequences. Nucleic Acids Res. 2017;45:D128&#x2013;D134. doi: 10.1093/nar/gkw1008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1008</ArticleId><ArticleId IdType="pmc">PMC5210518</ArticleId><ArticleId IdType="pubmed">27794554</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40:37&#x2013;52. doi: 10.1093/nar/gkr688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr688</ArticleId><ArticleId IdType="pmc">PMC3245920</ArticleId><ArticleId IdType="pubmed">21911355</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25. doi: 10.1186/gb-2009-10-3-r25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2009-10-3-r25</ArticleId><ArticleId IdType="pmc">PMC2690996</ArticleId><ArticleId IdType="pubmed">19261174</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 2012;9:357&#x2013;359. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245&#x2013;5250. doi: 10.1158/0008-5472.CAN-04-0496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-0496</ArticleId><ArticleId IdType="pubmed">15289330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru Y, et al. The multiMiR R package and database: Integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42:e133. doi: 10.1093/nar/gku631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku631</ArticleId><ArticleId IdType="pmc">PMC4176155</ArticleId><ArticleId IdType="pubmed">25063298</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler&#x2014;A web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 2007;35:W193&#x2013;W200. doi: 10.1093/nar/gkm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm226</ArticleId><ArticleId IdType="pmc">PMC1933153</ArticleId><ArticleId IdType="pubmed">17478515</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>